Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Edelstein

Showing results (161-170 of 231) with videos related to

Pageof 24
Sort By:
Epidemiology and Infection|April 12, 2012
Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemiaJ H Han, W B Bilker, P H Edelstein, et al.
Epidemiology and Infection|October 18, 2008
Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adultsJ H Flory, M Joffe, N O Fishman, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1991
A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumoniaH Edelstein, V Chirurgi, S Oster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Veillonella myositis in an immunocompromised patientM G Beumont, J Duncan, S D Mitchell, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremiaJennifer H Han, Kara B Mascitti, Paul H Edelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapyEbbing Lautenbach, Joshua P Metlay, Warren B Bilker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2001
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomesE Lautenbach, J B Patel, W B Bilker, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 8, 2010
Relapsing Legionella pneumophila cellulitis: a case report and review of the literatureJennifer H Han, Josephine C Nguyen, Shuko Harada, et al.
Journal of Clinical Microbiology|January 29, 2010
Prevalence of non-penicillin-susceptible group B streptococcus in Philadelphia and specificity of penicillin resistance screening methodsKei Kasahara, Andrew J Baltus, Sun-Hwa Lee, et al.
Zoonoses and Public Health|January 12, 2012
Potential for pet animals to harbour methicillin-resistant Staphylococcus aureus when residing with human MRSA patientsD O Morris, E Lautenbach, T Zaoutis, et al.
Pageof 24

Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Epidemiology and Infection|April 12, 2012
Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemiaJ H Han, W B Bilker, P H Edelstein, et al.
Epidemiology and Infection|October 18, 2008
Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adultsJ H Flory, M Joffe, N O Fishman, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1991
A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumoniaH Edelstein, V Chirurgi, S Oster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Veillonella myositis in an immunocompromised patientM G Beumont, J Duncan, S D Mitchell, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremiaJennifer H Han, Kara B Mascitti, Paul H Edelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapyEbbing Lautenbach, Joshua P Metlay, Warren B Bilker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2001
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomesE Lautenbach, J B Patel, W B Bilker, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 8, 2010
Relapsing Legionella pneumophila cellulitis: a case report and review of the literatureJennifer H Han, Josephine C Nguyen, Shuko Harada, et al.
Journal of Clinical Microbiology|January 29, 2010
Prevalence of non-penicillin-susceptible group B streptococcus in Philadelphia and specificity of penicillin resistance screening methodsKei Kasahara, Andrew J Baltus, Sun-Hwa Lee, et al.
Zoonoses and Public Health|January 12, 2012
Potential for pet animals to harbour methicillin-resistant Staphylococcus aureus when residing with human MRSA patientsD O Morris, E Lautenbach, T Zaoutis, et al.
Pageof 24